{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:30:37Z","timestamp":1790814637716,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.msard.2025.106791","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:12:37Z","timestamp":1759633957000},"page":"106791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Unveiling oxidative stress in multiple sclerosis phenotypes: Exclusion of confounding variables for accurate correlation with disability status"],"prefix":"10.1016","volume":"104","author":[{"given":"Amirali","family":"Ghahremani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5640-5440","authenticated-orcid":false,"given":"Hasan","family":"Namdar Ahmadabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106791_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101873","article-title":"Glutamate and nitric oxide as biomarkers for disease activity in patients with multiple sclerosis","volume":"38","author":"abdel Naseer","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106791_bib0002","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s13760-012-0059-4","article-title":"Evaluation of serum oxidant\/antioxidant balance in multiple sclerosis","volume":"112","author":"Acar","year":"2012","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.msard.2025.106791_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1973834","article-title":"New insights into the role of oxidative stress mechanisms in the pathophysiology and treatment of multiple sclerosis","volume":"2016","author":"Adamczyk","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.msard.2025.106791_bib0004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.33899\/mmed.2018.160001","article-title":"The effect of interferon-beta on oxidative stress in patients with multiple sclerosis","volume":"40","author":"Aldabagh","year":"2018","journal-title":"Ann. Coll. Med. Mosul"},{"key":"10.1016\/j.msard.2025.106791_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2016.09.009","article-title":"Nitric oxide levels in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"61","author":"Assmann","year":"2016","journal-title":"Nitric Oxide"},{"issue":"4","key":"10.1016\/j.msard.2025.106791_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214738","article-title":"Epidemiology of multiple sclerosis in Iran: a systematic review and meta-analysis","volume":"14","author":"Azami","year":"2019","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.msard.2025.106791_bib0007","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(18)30454-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Cooper","year":"2019","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106791_bib0008","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2025.106791_bib0009","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1474-4422(22)00040-0","article-title":"Multiple sclerosis: two decades of progress","volume":"21","author":"Cree","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106791_bib0010","article-title":"Nitric oxide involvement in the disability and active disease of multiple sclerosis: systematic review and meta-analysis","author":"da Silva","year":"2024","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.msard.2025.106791_bib0011","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.niox.2024.01.006","article-title":"Nitric oxide involvement in the disability and active disease of multiple sclerosis: systematic review and meta-analysis","volume":"145","author":"da Silva","year":"2024","journal-title":"Nitric Oxide"},{"issue":"5","key":"10.1016\/j.msard.2025.106791_bib0012","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bbadis.2018.03.007","article-title":"Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects","volume":"1864","author":"De Riccardis","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.msard.2025.106791_bib0013","article-title":"Expression and enzyme activity of MnSOD and catalase in peripheral blood mononuclear cells isolated from multiple sclerosis patients","volume":"1","author":"Emamgholipour","year":"2015","journal-title":"Arch. Med. Lab. Sci."},{"issue":"1","key":"10.1016\/j.msard.2025.106791_bib0014","first-page":"49","article-title":"Do catalase and glutathione peroxidase protect blood platelets from lipid peroxidation in multiple sclerosis?","volume":"27","author":"Fija\u0142kowski","year":"2018","journal-title":"Adv. Psychiatry Neurol.\/Post\u0119py Psychiatr. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2025.106791_bib0015","doi-asserted-by":"crossref","first-page":"e2596","DOI":"10.1002\/brb3.2596","article-title":"Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: a cross-sectional case\u2013control study","volume":"12","author":"Ghahremani","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.msard.2025.106791_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102941","article-title":"Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics","volume":"51","author":"Ghonimi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106791_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/961863","article-title":"Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment","volume":"2014","author":"Gironi","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.msard.2025.106791_bib0018","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ncl.2017.08.012","article-title":"Multiple sclerosis in the contemporary age: understanding the millennial patient with multiple sclerosis to create next-generation care","volume":"36","author":"Hansen","year":"2018","journal-title":"Neurol. Clin."},{"issue":"1","key":"10.1016\/j.msard.2025.106791_bib0019","article-title":"Comparison of antioxidant status and vitamin D levels between multiple sclerosis patients and healthy matched subjects","volume":"2014","author":"Hejazi","year":"2014","journal-title":"Mult. Scler. Int."},{"issue":"8","key":"10.1016\/j.msard.2025.106791_bib0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/bmm-2016-0097","article-title":"Oxidative stress-related biomarkers in multiple sclerosis: a review","volume":"10","author":"Ibitoye","year":"2016","journal-title":"Biomark. Med."},{"key":"10.1016\/j.msard.2025.106791_bib0021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.msard.2017.11.010","article-title":"Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients","volume":"19","author":"Juybari","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1-2","key":"10.1016\/j.msard.2025.106791_bib0022","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinbiochem.2014.09.023","article-title":"Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis","volume":"48","author":"Karl\u00edk","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.msard.2025.106791_bib0023","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00415-005-0037-3","article-title":"Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis","volume":"253","author":"Koch","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106791_bib0024","article-title":"Multiple sclerosis: evaluation of purine nucleotide metabolism in central nervous system in association with serum levels of selected fat-soluble antioxidants","volume":"2014","author":"Kura\u010dka","year":"2014","journal-title":"Mult. Scler. Int."},{"issue":"4","key":"10.1016\/j.msard.2025.106791_bib0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1179\/1351000211Y.0000000007","article-title":"Aminoguanidine and N-acetyl-cysteine supress oxidative and nitrosative stress in EAE rat brains","volume":"16","author":"Ljubisavljevic","year":"2011","journal-title":"Redox Rep."},{"key":"10.1016\/j.msard.2025.106791_bib0026","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10571-013-9944-5","article-title":"Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic","volume":"33","author":"Ljubisavljevic","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1-2","key":"10.1016\/j.msard.2025.106791_bib0027","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2013.02.012","article-title":"Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course","volume":"257","author":"Miller","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2025.106791_bib0028","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10072-021-05750-w","article-title":"Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis","volume":"43","author":"Mirmosayyeb","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106791_bib0029","article-title":"Evaluation of the diagnostic and predictive value of serum levels of ANT1, ATG5, and Parkin in multiple sclerosis","volume":"197","author":"Nourazarian","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2025.106791_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2022.103936","article-title":"Comparison of the antioxidant properties of serum and plasma samples as well as glutathione under environmental and pharmacological stress factors involving different classes of drugs","volume":"94","author":"Olszowy-Tomczyk","year":"2022","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.msard.2025.106791_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103228","article-title":"The role of oxidative stress and haematological parameters in relapsing-remitting multiple sclerosis in Kurdish population","volume":"56","author":"Rasoul","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.msard.2025.106791_bib0032","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3109\/00207454.2013.801844","article-title":"Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing\u2013remitting multiple sclerosis","volume":"123","author":"Sanoobar","year":"2013","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.msard.2025.106791_bib0033","article-title":"Catalase: structure, properties, functions","volume":"60","author":"\u015acibior","year":"2006","journal-title":"Adv. Hyg. Exp. Med."},{"key":"10.1016\/j.msard.2025.106791_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2891-13-62","article-title":"Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis","volume":"13","author":"Socha","year":"2014","journal-title":"Nutr. J."},{"key":"10.1016\/j.msard.2025.106791_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2018.06.005","article-title":"Associations of genetic variations of the endothelial nitric oxide synthase gene and environmental carcinogens with oral cancer susceptibility and development","volume":"79","author":"Su","year":"2018","journal-title":"Nitric Oxide"},{"issue":"7","key":"10.1016\/j.msard.2025.106791_bib0036","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.3390\/ijms21072431","article-title":"Exploring the etiological links behind neurodegenerative diseases: inflammatory cytokines and bioactive kynurenines","volume":"21","author":"Tanaka","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.msard.2025.106791_bib0037","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/biomedicines8100406","article-title":"Monitoring the redox status in multiple sclerosis","volume":"8","author":"Tanaka","year":"2020","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.msard.2025.106791_bib0038","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clinbiochem.2012.01.023","article-title":"Peripheral oxidative stress in relapsing\u2013remitting multiple sclerosis","volume":"45","author":"Tasset","year":"2012","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.msard.2025.106791_bib0039","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12031-020-01672-y","article-title":"Oxidative\/nitroxidative stress and multiple sclerosis","volume":"71","author":"Tobore","year":"2021","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.msard.2025.106791_bib0040","first-page":"217","article-title":"Concentration of elements in serum of patients affected by multiple sclerosis with first demyelinating episode: a six-month longitudinal follow-up study","volume":"41","author":"Visconti","year":"2005","journal-title":"Ann. Ist. super. sanita"},{"issue":"4","key":"10.1016\/j.msard.2025.106791_bib0041","first-page":"342","article-title":"Multiple sclerosis phenotypes as a continuum: the role of neurologic reserve","volume":"11","author":"Vollmer","year":"2021","journal-title":"Neurol.: Clin. Pract."},{"issue":"6","key":"10.1016\/j.msard.2025.106791_bib0042","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1083\/jcb.201708007","article-title":"Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling","volume":"217","author":"Wang","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.msard.2025.106791_bib0043","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fnins.2020.00823","article-title":"Oxidative stress marker aberrations in multiple sclerosis: a meta-analysis study","volume":"14","author":"Zhang","year":"2020","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.msard.2025.106791_bib0044","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3390\/antiox12091675","article-title":"The applications and mechanisms of superoxide dismutase in medicine, food, and cosmetics","volume":"12","author":"Zheng","year":"2023","journal-title":"Antioxidants"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:37:50Z","timestamp":1784345870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"alternative-id":["S2211034825005334"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106791","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling oxidative stress in multiple sclerosis phenotypes: Exclusion of confounding variables for accurate correlation with disability status","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106791"}}